An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...

I have bad knee arthritis.

Telix has delivered a string of radiopharmaceuticals greatest hits with more to come but there have also been some misses ...

The Barbara Ann Karmanos Cancer Institute has expanded access of three groundbreaking cancer therapies to Karmanos Cancer Network locations in Michigan. As part of Karmanos' theranostics program, ...

Denosumab therapies are used to increase bone mass and treat osteoporosis, as well as address bone complications in cancer.

The Barbara Ann Karmanos Cancer Institute in Detroit has expanded access to three radiopharmaceutical cancer therapies to Karmanos Cancer Network locations in Michigan.

After a series of regulatory and clinical setbacks for Sanofi’s tolebrutinib, the French pharma has scored a victory for the ...

Global biopharmaceutical company Biocon Limited on Tuesday said Health Canada has granted a Notice of Compliance for its biosimilar Bosaya and Vevzuo, both denosumab-based products used in treating ...